Keywords

35.1 Introduction, Epidemiology and Risk Factors

Placenta Accreta Spectrum (PAS) also known as abnormally invasive placenta (AIP), describes the clinical situation when after delivery of the fetus the placenta does not detach spontaneously from the uterus and if forcibly removed can cause potentially catastrophic maternal hemorrhage [1,2,3]. This “spectrum disorder” ranges from abnormally adherent to deeply invasive placental tissue, traditionally categorized as placenta accreta, when villi are directly attached to the myometrium without interposing decidua (abnormally adherent); placenta increta, when the villi penetrate the myometrium up to the uterine serosa (abnormally invasive); and placenta percreta, when the villi penetrate through the uterine serosa to invade neighboring tissues and organs, such as the bladder (abnormally invasive); but all grades can co-exist within the same placenta [4, 5]. The incidence of PAS has increased worldwide, most likely associated with the rising rates of cesarean delivery [1]. Cesarean section is the greatest risk factor, and therefore PAS could be seen as an iatrogenic disease [6]. Other surgical risk factors include uterine procedures (such as curettage, myomectomy, endometrial ablation, manual removal of the placenta, or adhesiolysis for Asherman syndrome). Advanced maternal age, increasing parity and In vitro Fertilization (IVF) are additional risk factors. Even though PAS is still rare (0.83.1 per 1000 births after a prior cesarean), PAS is the most common reason for peripartum hysterectomy and contributes to the current failure to reduce maternal death rate in high-income countries.

Antenatal recognition of PAS is vital to initiate multidisciplinary planning for a safe delivery in a center of expertise which has been shown to reduce maternal mortality and morbidity. However, the available evidence is complicated by methodologically flawed study designs and variations in the definitions and diagnostic criteria used. In an attempt to address these problems international groups, including the International Federation of Gynecology and Obstetrics (FIGO) and the International Society for AIP (IS-AIP), have published proposals for standardized diagnostic criteria [7] and clinical classification [8].

35.2 Clinical Implications

Optimal management requires accurate antenatal diagnosis, multidisciplinary teamwork, and a robust perinatal management strategy. During routine care, the mid-pregnancy fetal anomaly scan should include placental localization thereby identifying women at risk of persisting low-lying placenta or who have a placenta previa. Women with significant clinical risk factors for PAS (most notably placenta previa and previous cesarean section) should undergo further diagnostic evaluation by an experienced sonographer [9]. MRI is reported to be of adjunctive value for posterior placenta previa, to assess potential bladder invasion and could be a useful tool for multidisciplinary planning for surgery [10,11,12]. Patients with suspected PAS should be referred to a center of excellence. FIGO recommends the use of a clinical grading system for diagnosis at delivery [9] (Table 35.1).

Table 35.1 FIGO clinical classification for the diagnosis of Placenta accreta spectrum (PAS) at delivery [8]
Fig. 35.1
The ultrasonic image with hyperechoic structure with a bright margin as indicated by an arrow and catheter is labeled. In the image on the right is an ultrasonic image on a power doppler to check the vascularity in the affected region as indicated by an arrow.

(a) Transabdominal 2D Ultrasound. Loss of “clear zone” (arrow) and (b) Uterovesical hypervascularity in 2D Doppler ultrasound (arrow) in 30 weeks of gestational age

Although the sensitivity of ultrasound diagnosis of PAS is crucial, there is a price of a false-positive diagnosis. A midline laparotomy proceeding straight to post-cesarean hysterectomy is frequently used when a PAS is anticipated. Further risks for complications include the frequently used prophylactic balloons in the pelvic vasculature or planned preterm delivery, resulting in possible iatrogenic maternal and neonatal morbidity [13]. Therefore, the positive predictive value (PPV) and negative predictive value (NPV) of the ultrasound signs are as important as the sensitivity and specificity. Practically, the PPV indicates the confidence with which clinicians can proceed straight to post-cesarean hysterectomy without removing the placenta. In contrast, the NPV characterizes the confidence with which obstetricians can remove a placenta previa without concerns of severe bleeding [14].

Clinical outcomes of women affected by PAS are related to the depth and location of placental invasions, such as bladder involvement or parametrium invasion, although variability in surgical outcome in women presenting with the same degree of placental invasion has been described. A recent approach to prenatal ultrasound staging of PAS showed a good correlation with surgical outcomes, depth of invasion, and the FIGO clinical grading system [15]. Although prenatal diagnosis by ultrasound is an extremely valuable tool, the absence of ultrasound signs does not preclude the diagnosis of focal PAS especially at the abnormally adherent, accreta end of the spectrum and clinical factors as described above remain important in identifying women at high risk.

35.3 Ultrasound Findings

Antenatal ultrasound is the primary tool to identify the location of the placenta and its relation to the uterine scar. The detecting PAS, however, still relies on subjective interpretation of typical sonographic signs of the uterine wall and placenta with two-dimensional (2D) grayscale and color Doppler imaging. Its accuracy depends not only on the experience of the operator, which is limited in many settings by the rarity of the condition but also on technical aspects. Several signs have been reported with varying results in diagnostic accuracy, mainly due to differences in definitions of the ultrasound signs (e.g., how abnormal lacunae are defined), as well as the final clinical diagnosis. To improve consistency and allow for comparison of the ultrasound markers, the IS-AIP proposed a uniform description of ultrasound signs used for the prenatal diagnosis of PAS and an adhoc International Expert Group produced a proforma protocol for the ultrasound assessment (Tables 35.2 and 35.3) [16, 17].

Table 35.2 Grayscale 2D ultrasound signs of PAS and definitions
Table 35.3 Color Doppler ultrasound signs of PAS and definitions [16, 17]
Fig. 35.2
The ultrasonic image with hypoechoic structures with bright margins as indicated by an arrow and cervix can be visualized. The power doppler to check the vascularity of the structure of the placenta is indicated by an arrow.

(a) Transvaginal 2D. Bladder wall interruption (arrow) in lower bladder and (b) Subplacental hypervascularity (arrow) in 27 weeks of gestational age

Fig. 35.3
The ultrasonic image with hypoechoic structure with margins indicated by arrows. The adjacent structure is checked for vascularity as indicated by arrows in the vessels.

(a) Undetectable of myometrial wall (arrow) in Transabdominal 2D ultrasound and (b) bridging vessel which is appearing to extend from placenta into bladder (arrow) in 33 weeks of gestational age

Recent systematic reviews and meta-analysis of ultrasound studies in pregnancies at risk of PAS (women with a prior cesarean delivery, presenting with the anterior low placenta or placenta previa) found that the overall performance of ultrasound, when performed by skilled operators, was very good with a sensitivity and specificity of >95% [18,19,20]. Myometrial thinning, bladder wall interruption, and uterovesical hypervascularity were associated with the most severe types of PAS (percreta) [21]. Placental lacunae and the increased vascularity of the placental bed with large feeder vessels entering the lacunae were the most common ultrasound signs associated with PAS [8]. The highest level of inter-observer agreement for ultrasound signs was found for loss of clear zone, myometrial thinning, the presence of lacunar feeding vessels on 2D color Doppler and crossing vessels and lacunae on 3D color Doppler [4]. Abnormal implantation of the placenta is not always homogeneous, but usually combines areas of abnormal adherence and invasion in the same placenta. This may explain why yet no single sign or combination of markers has been found to be specific for the depth of PAS on histology.

35.4 Color Doppler Ultrasound

The introduction of color Doppler ultrasound has enabled better visualization of the uteroplacental circulation: PAS is often associated with hypervascularization patterns within the placenta and between the placental basal plate and underlying tissues (myometrium, bladder wall). However, despite attempts to standardize these signs, the exact interpretation of color Doppler ultrasound findings remains subjective [22].

The combination of grayscale and color Doppler imaging ultrasound markers is reported to have increased the sensitivity of ultrasound imaging with NPV ranging between 95% and 98%. In a recent study, ultrasound staging had a high correlation with surgical outcome, depth of invasion, and the FIGO classification system [15].

35.5 3D and Power Doppler Imaging

The 3D color Doppler technique has been increasingly used: the placental borders can be manually traced and placental volume can be assessed and measured [22]. In studies to diagnose PAS with three-dimensional (3D) power Doppler, the placenta was assessed in various ways: subjective for abnormal vascularity; intra-placental hypervascularity, inseparable cotyledonal (fetal) and intervillous (maternal) circulations or tortuous confluent vessels across the placental width [14, 23]. In order to quantify hypervascularity, new measurements have been suggested, such as 3D Volume Rendering for placental–bladder interface, the area of confluence or the vascular index [13, 22, 24]. In prospective studies, these measurements differentiated between the presence and absence of PAS and were more predictive of severe cases of PAS than were the 2D ultrasound signs [13]. Although these findings are promising, they need to be confirmed in multicenter trials before appropriate clinical applications can be determined (Figs. 35.6 and 35.6).

Fig. 35.4
An ultrasonic image with hypoechoic structure and hyperechoic margin to show hollow spaces as indicated by arrows. The hollow space is checked for its vascularity is checked in the vessels.

(a) Large and irregular Abnormal placental lacunae (arrow) in Transabdominal 2D ultrasound with (b) Placental lacunae feeder vessels (arrow) in 2D Doppler ultrasound (arrow) in 33 weeks of gestational age

35.6 Technical Aspects [16]

35.6.1 Bladder Volume [25]

PAS is most commonly associated with an anterior low-lying placenta or placenta previa. To visualize the anterior lower segment of the uterus, an ultrasound examination must be carried out with a full bladder (around 250–300 mL). Without a full bladder, signs such as bladder wall interruption, placental bulge, and uterovesical hypervascularity cannot be appropriately assessed. On the other hand, if the bladder is overfilled (>500 mL), compression of the placental bed may obscure the vascular architecture and change the appearance of the interface.

35.6.2 Angle of Insonation

The best angle of insonation of the area of interest, the border between the placenta and the myometrium, is 90°; this angle is not easily achieved by either transabdominal or transvaginal scanning. If the angle is close to 0°, artifacts can make the correct analysis of the placental-myometrial interface difficult and result in false-positives in particular regarding “myometrial thinning.”

35.6.3 Transabdominal and Transvaginal Probe Pressure

The required pressure used by the operator on the probe depends on the woman’s body habitus and distribution of adipose tissue. Pressing too hard may result in artifacts such as “loss of the clear zone” and myometrial thinning.

35.6.4 Color Doppler and (3D) Power Doppler

Attention must be paid to using the appropriate blood flow velocity settings (pulse repetition frequency, PRF, usually 1.3 kHz for color Doppler and 0.9 kHz for power Doppler). If the PRF is too low there will be increased aliasing potentially leading to the suggestion of hypervascularization. To select the appropriate Doppler setting the gain should be increased until the image is saturated with color and then slowly reduce the gain until the apparent artifacts disappear (called the Sub-Noise Gain (SNG) setting). Using the SNG ensures that the difference in Doppler signal attenuation caused by differences in the amount and type of tissue being insonated is appropriately corrected for.

35.7 Clinical Examples

35.7.1 Clinical Cases-Imaging-Related to Clinical Findings During Surgery

Case 1

Mrs. A, 36-year-old, Gravida 4, Parity 3, 35 weeks of gestational age with three previous cesarean sections (Fig. 35.7).

Fig. 35.5
The images of ultrasound of the abdomen area, image a, is indicated by a wall. Image b, is bright and 3 dimensional the indicated part is shown by the arrows. In part c, defected organ where the defected part is indicated by the arrows.

(a) Loss of “clear zone” and undetected myometrial wall (arrow), which is seen in (b) 3D volume rendering ultrasound (axial plane), which is predominantly a uterine wall defect in the left lower uterine segment (arrow) in 33 weeks of gestational age and (c) proven during surgery (arrow) at 34 weeks of gestational age

Fig. 35.6
The image has 2 parts, part a is a 3 dimensional doppler that has villi like structures and a bubble attached to it. In part b, the placenta during the surgery.

(a) 3D power Doppler in diffuse placenta percreta with intraplacental hypervascularity, inseparable cotyledons and intervillous circulation, irregular branches of intraplacental vascularity which is found in (b) placenta percreta during surgery

Fig. 35.7
An image has 4 images, part a, placental bulge as indicated by an arrow. In part b, hypervascularity in the placenta in a power doppler as indicated by an arrow. In part c, 3 dimensional ultrasonic placental images. In part d, The placenta on a uterus after surgery.

(a) Placental Bulge (arrow) in Transabdominal 2D Ultrasound with (b) uterovesical hypervascularity (arrow) that analyze using 3D volume rendering ultrasound (c) in the same ultrasound probe plane shows highly suspicious of placenta percreta invasion (arrow) that proven (d) during surgery (arrow)

Fig. 35.8
The image has 5 parts, part a, is ultrasonic image with visibility of catheter as indicated by arrow. In part b, with a doppler to check vascularity in the ultrasonic image of the uterus. In part c, The arrow is indicated on a hyperechoic and hypoechoic structure. Part d, 3 dimensional view of the uterus and catheter, part e is a muscular organ

(a) Loss of “clear zone” (arrow), (b) no evidence of subplacental hypervascularity and uterovesical hypervascularity. (c) Slightly placental bulge in 2D ultrasound with (d) small area of placental invasion in 3D volume rendering ultrasound that proven as placenta accreta during surgery (e)

Case 2

Mrs. L, 30-year-old, Gravida 2, Parity 1, 33 weeks gestational age with one previous cesarean section (Fig. 35.8).

All examinations were carried out using a transabdominal probe from 4.0 to 6.0 MHz or transvaginal 5.0–7.0 MHz (GE Voluson® 730, General Electric, and Samsung WS80A Elite, Samsung); when using color Doppler ultrasound, the pulse repetition frequency (PRF) or scale was set at 1.3 KHz, but this was adapted to identify the presence of placental lacunar flow.